drugset / Trial / NCT01640249
A Study of LY3006072 in Healthy Participants
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this study is to evaluate how safe LY3006072 (study drug) is and whether it causes any side effects. The study will also measure how much of the study drug gets into the blood stream and how long it takes the body to get rid of the study drug. The study drug will be given in the morning or evening with or without a meal. This is the first time that this study drug is being given to humans. This study is for research purposes only and is not intended to treat any medical condition.
Timeline
- Start
- 2012-07-24
- Primary completion
- 2012-11-26
- Completion
- 2012-11-26
Outcome
Outcome not reported
Stopped: “Study terminated due to unacceptable pharmacokinetic (PK) profile.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3006072 | Unknown | 1 mg | Oral |
| Subject | LY3006072 | Unknown | 3 mg | Oral |
| Subject | LY3006072 | Unknown | 10 mg | Oral |
| Subject | LY3006072 | Unknown | 20 mg | Oral |
| Subject | LY3006072 | Unknown | 40 mg | Oral |
Indications
No indication recorded.